Cara Janusz to Health Policy
This is a "connection" page, showing publications Cara Janusz has written about Health Policy.
Connection Strength
0.293
-
Jauregui B, Garcia AG, Bess Janusz C, Blau J, Munier A, Atherly D, Mvundura M, Hajjeh R, Lopman B, Clark AD, Baxter L, Hutubessy R, de Quadros C, Andrus JK. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience. Vaccine. 2015 May 07; 33 Suppl 1(0 1):A28-33.
Score: 0.121
-
Kieninger MP, Caballero EG, Sosa AA, Amarilla CT, Jáuregui B, Janusz CB, Clark AD, Castellanos RM. Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay. Vaccine. 2015 May 07; 33 Suppl 1:A143-53.
Score: 0.030
-
Mezones-Holguin E, Canelo-Aybar C, Clark AD, Janusz CB, Jaúregui B, Escobedo-Palza S, Hernandez AV, Vega-Porras D, González M, Fiestas F, Toledo W, Michel F, Suárez VJ. Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine. 2015 May 07; 33 Suppl 1:A154-66.
Score: 0.030
-
Jauregui B, Janusz CB, Clark AD, Sinha A, Garcia AG, Resch S, Toscano CM, Sanderson C, Andrus JK. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions. Vaccine. 2015 May 07; 33 Suppl 1:A21-7.
Score: 0.030
-
Valdés W, Janusz CB, Molina Aguilera IB, Mendoza L, Díaz IY, Resch S. Tracking financial flows for immunization in Honduras. Vaccine. 2015 May 07; 33 Suppl 1:A85-92.
Score: 0.030
-
Duclos P, Dumolard L, Abeysinghe N, Adjagba A, Janusz CB, Mihigo R, Mosina L, Takashima Y, Oztürk MH. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012. Vaccine. 2013 Nov 04; 31(46):5314-20.
Score: 0.027
-
Duclos P, Ortynsky S, Abeysinghe N, Cakmak N, Janusz CB, Jauregui B, Mihigo R, Mosina L, Sadr-Azodi N, Takashima Y, Dumolard L, Gacic-Dobo M. Monitoring of progress in the establishment and strengthening of national immunization technical advisory groups. Vaccine. 2012 Nov 26; 30(50):7147-52.
Score: 0.024